Regencell Bioscience Holdings Limited

NasdaqCM RGC

Regencell Bioscience Holdings Limited Dividend Yield on December 05, 2024

Regencell Bioscience Holdings Limited Dividend Yield is NA on December 05, 2024, a NA change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.

Regencell Bioscience Holdings Limited 52-week high Dividend Yield is NA on December 05, 2024, which is NA below the current Dividend Yield.
Regencell Bioscience Holdings Limited 52-week low Dividend Yield is NA on December 05, 2024, which is NA below the current Dividend Yield.
Regencell Bioscience Holdings Limited average Dividend Yield for the last 52 weeks is NA.

Key data

Date	Dividend Yield	Free Cash Flow Yield	Earnings Yield	Enterprise Value (EV)

NasdaqCM: RGC

Regencell Bioscience Holdings Limited

CEO	Mr. Yat-Gai Au
IPO Date	July 16, 2021
Location	Hong Kong
Headquarters	First Commercial Building
Employees	12
Sector	Health Care
Industries Biotechnology Pharmaceuticals Research & Consulting

Description

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Key trends

Past 5 years